Additional gains for the days/weeks/months to comeI find it hard to calculate a value of the proprietary platform as an isolated entity, but for sure it's substantial. Versatile and disruptive! Pharmaceuticals and cosmetics. Nevertheless, it has been long overdue for the share price to start to reflect the value - including the existing SGLT2 deal of course. Great that there's a gain folllowed by accumulation before next gain. In this way the share price will be sustainable.
Must say that based in the last interview I don't expect the first Skin Lightening deal in the very near future - but probably before the summer is over and it could be as many as 4-5 deals altogether.
In the meantime I expect an Wanbang SGLT2 update and maybe something additional from them as Howard has indicated. The results from the second TFC-1067 trial in China should be due very soon. We might also get at least an update, if not another deal, on SGLT2 for pets.
I would be surprised if the share price is below 2 bucks before the end of the autumn.